Company Long-Term Loans and Borrowings: cortigent.com (CRGT)

The asset value of Cortigent, Inc. (CRGT) on GURU.Markets, as reflected in this chart, underscores the company's dependence on implant test results and government support for neural interfaces, where the indicator stands at . The business relies on the development of organ stimulation systems, whose margins are expected to surge following the automation of chip production. Currently, the company lacks pricing power as it awaits FDA approval to set prices for its developments.

Cortigent, Inc. (CRGT) Company Long-Term Debts: for the period 07/04/2022 - 10/29/2026

Summary analytical data breakdowns for Cortigent (CRGT)

- market price and analyst price targets:
Stock Price Cortigent Inc|CRGT - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Cortigent|CRGT - Total Company Value
- book capitalization information:
Net Asset Value per Share Cortigent|CRGT - Book Capitalization|Market Cap to Net Assets Ratio cortigent.com|CRGT - Aggregate Company Assets
- debt level and financial liquidity data:
Debt to Capital Cortigent, Inc.|CRGT - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Cortigent Inc|CRGT - Company Total Debt|Debt to Book Capital Cortigent|CRGT - Company Long-Term Debts|Short-Term Debt Volume Cortigent
Fundamental company valuation:Cortigent, Inc. CRGT

An analysis of the debt load of Cortigent, Inc. (CRGT) allows for an assessment of the issuer's financial stability. The company's long-term debt statistics capture the total liabilities with maturities exceeding twelve months. An increase in this metric may indicate investments in costly neurointerfaces for specialized clinics. A stable level of borrowing confirms a balance between capital and development. Credit control is critically important for scaling brain stimulation technologies.

Who Cortigent, Inc. competes with

Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|XENE (Xenon Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Liabilities vikingtherapeutics.com (VKTX)|Company Long-Term Debt Supernus (SUPN)|CPRX - Long-Term Debt|Company Long-Term Debt Denali Therapeutics Inc DNLI|Company Long-Term Loans and Borrowings HRMY|BHVN: Company Long-Term Liabilities|amylyx.com - Amount of Long-Term Liabilities|TRVI: Company Long-Term Debts|PRAX - Long-Term Debt Volume|AVXL (Anavex Corp) - Company Long-Term Debts|CBLL - Long-Term Indebtedness|Company Long-Term Debts PRTA|ALEC - Long-Term Debt|Company Long-Term Debt Annexon ANNX|OMER: Company Long-Term Indebtedness|NGNE: Company Long-Term Liabilities|AC Immune Inc - Amount of Long-Term Liabilities|VYGR (Voyager Therapeutics) - Company Long-Term Liabilities|neumoratx.com - Company Long-Term Loans and Borrowings|SCLX (Scilex) - Company Long-Term Debts|Tevogen Bio Holdings Inc. (TVGN) - Long-Term Debt Volume|Company Long-Term Debt Alpha Cognition (ACOG)|cogrx.com - Company Long-Term Indebtedness|Company Long-Term Debts IKT (Inhibikase Therapeutics)|SAVA - Company Long-Term Liabilities|ASRT: Company Long-Term Liabilities|Long-Term Debt Volume Coya Therapeutics, Inc. COYA|VTGN: Company Long-Term Debts|Company Long-Term Liabilities Ovid Therapeutics|Company Long-Term Debt Acumen Pharmaceuticals|CRVO: Company Long-Term Loans and Borrowings|Company Long-Term Debts ATHE|clene.com (CLNN) - Long-Term Indebtedness|PepGen - Company Long-Term Liabilities|Amount of Long-Term Liabilities JUNS (jupiterneurosciences.com)|RLMD - Company Long-Term Debt|ANVS (annovisbio.com) - Company Long-Term Indebtedness|GRCE: Company Long-Term Debts|Long-Term Debt Firefly Neuroscience, Inc. (AIFF)|Company Long-Term Liabilities KLTO|Company Long-Term Debts NeuroSense Therapeutics, Ltd.|Company Long-Term Debt Reviva Pharmaceuticals (RVPH)|MTVA (metaviatx.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt NeurAxis NRXS|Helius Medical Technologies, Inc. (HSDT) - Long-Term Debt|Passage Bio Corp - Company Long-Term Debts|Neuphoria Therapeutics Inc. (NEUP) - Company Long-Term Liabilities|Minerva Neurosciences (NERV) - Company Long-Term Debt|Long-Term Debt athira.com (ATHA)|Company Long-Term Debt Addex Therapeutics Ltd|ALZN: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities CYCN (Cyclerion Therapeutics)|Amount of Long-Term Liabilities PTIX|Company Long-Term Debts KTTA (Pasithea Therapeutics Corp.)|Long-Term Debt Volume avenuetx.com (ATXI)|BrainStorm Cell Therapeutics - Company Long-Term Debts|Long-Term Indebtedness Cara Therapeutics Inc. (CARA)|CHRO: Company Long-Term Debts|Long-Term Debt Eliem Therapeutics Inc. (ELYM)|Company Long-Term Debt Intra-Cellular Therapies Inc.|Company Long-Term Indebtedness LBPH (longboardpharma.com)|Company Long-Term Liabilities MRNS (Marinus Pharmaceuticals, Inc.)|Amount of Long-Term Liabilities NKGN|NeuroBo - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings SAGE|Synaptogenix, Inc. - Company Long-Term Debts|Long-Term Debt Volume trevena.com TRVN|vigilneuro.com (VIGL) - Company Long-Term Debt|Company Long-Term Indebtedness WENA|CERE (Cerevel) - Company Long-Term Debts